drugset / Trial / NCT00575302

Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age

NCT00575302

Phase 4 Withdrawn 400 enrolled Centre Hospitalier Chretien EMD Serono · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

In In vitro fertilization (IVF) treatment, poor responder patients of more than 38 years old are randomized prospectively into two dosages of gonadotrophins. The outcome of treatment will be analyzed.

Timeline

Start
2007-12
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonal-f Protein / enzyme biologic 300 iu
Subject Gonal-f Protein / enzyme biologic 450 iu

Indications